Status:
COMPLETED
Covered or Uncovered Bile Duct Stents
Lead Sponsor:
Göteborg University
Conditions:
Bile Duct Neoplasms
Eligibility:
All Genders
Phase:
NA
Brief Summary
The study is investigator initiated. Tumors that gives the narrowing of the bile ducts prevents bile from flowing from the liver to the intestine resulting in jaundice and the risk of bacterial growth...
Detailed Description
0
Eligibility Criteria
Inclusion
- Patients with unresectable, distal bile duct stricture needing relieved endoscopically
- Expected survival greater than 3 months
- The patient must give written consent to participate in the study
Exclusion
- Stricture close to hilus
- Need for interpreter
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT01232101
Start Date
March 1 2007
End Date
August 1 2009
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kjell-Arne Ung, Dpt of Internal Medicine, Karnsjukhuset,
Skövde, Sweden, SE-54185